More PRNewswire
View Older Stories View Newer Stories-
Hyundai Motor Revives Vintage Seoul with PONY Heritage Model in ZEPETO 3D Avatar Universe
-
EISAI INVESTS IN C2N TO SUPPORT SIMPLIFYING THE DIAGNOSIS OF EARLY ALZHEIMER'S DISEASE TO BETTER SERVE PATIENTS
-
ITANDI and RENOSY (Thailand) Collaborate and Begin Development of a Real Estate SaaS Business in Thailand
-
Mission Roll Call Urges Congressional Support for Critical Fiscal Year 2024 Appropriations Bill
-
V2X to Participate in the Raymond James & Associates 45th Annual Institutional Investors Conference
-
Endotronix Presents Positive PROACTIVE-HF Clinical Trial Results for its Cordella Pulmonary Artery Sensor
-
PALADIN MANAGEMENT EXPANDS TEAM WITH TADD CRANE
-
Franco Mine PDAC Delegation Closes the Market
-
U.S. Used Planter Market Now Covered in Sandhills Global's Monthly Equipment, Truck, and Trailer Market Reports
-
FDA Roundup: March 5, 2024
-
INTEGRA ANNOUNCES C$10 MILLION BOUGHT DEAL PUBLIC OFFERING
-
Franco-Nevada Reports 2023 Results
-
rGen Consulting Opens Applications for Business Consulting and AI Foundations Program
-
Manulife announces additions to its Board of Directors
-
SinglePoint Inc. announces receipt of Cboe BZX Minimum Bid Price Notification and Confirms Commitment to Compliance with Exchange Requirements
-
Nuvei Announces Fourth Quarter and Fiscal 2023 Results
-
Locus Robotics Partners With Booktopia To Revolutionise Its Customer Order Fulfilment
-
Lilly Announces Details of Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting
-
BCN Strengthens Commitment to Service Delivery with Appointment of Tom Boggs as Vice President
-
Commerce Department Announces Affirmative Preliminary Subsidy Determinations on Imports of Aluminum Extrusions from China, Indonesia, Mexico, and Turkey, Wiley Rein LLP Reports
-
FIRST BANK AWARDED GREENWICH EXCELLENCE AWARDS IN SMALL BUSINESS BANKING
-
Nuvalent to Present New Preclinical Data on HER2-Selective Inhibitor, NVL-330, and ROS1-Selective Inhibitor, zidesamtinib, at AACR Annual Meeting 2024
-
Raintree Adds Availity as Claims and Payment Processing Strategic Partner
-
GLOBAL CLEAN ENERGY, INC. CONTINUES CORPORATE UPDATES
-
Elevation Oncology to Present Preclinical Proof-of-Concept Data for HER3-ADC Program at the American Association for Cancer Research (AACR) Annual Meeting 2024
-
Flash News: OKX DEX API Integrated by Port3 Network, a Leading Decentralized AI Data Network Built for Web3
-
McMaster University and Celesta Capital Launch Partnership to Nurture Development of Canadian Deep Tech Startups
-
Fusion Pharmaceuticals to Present Interim Data from the Phase 2 TATCIST Clinical Trial Evaluating FPI-2265 at the 2024 AACR Annual Meeting
-
Bristow Group Reports Fourth Quarter and Full Year 2023 Results
-
Bechtel and the American Foundation for Suicide Prevention Partner to Prevent Construction Worker Suicides
-
FDA Clears First Over-the-Counter Continuous Glucose Monitor
-
Banco BBVA Argentina S.A. announces Fourth Quarter and Fiscal Year 2023 results
-
Tricoci University of Beauty Culture Partners with Ashtae to Elevate Hair Care Education
-
OncoHost Selected to Present in Oral Minisymposium at American Association of Cancer Research (AACR) Annual Meeting 2024
-
/C O R R E C T I O N -- Zenni Optical/
-
Medtronic EVP & CFO Karen Parkhill to participate in the Barclays healthcare conference
-
Realtor.com® and Zillow Ink New Rental Listings Syndication Agreement
-
Cboe Global Markets Reports Trading Volume for February 2024
-
Immunitas Therapeutics to Present Preclinical Data Supporting Combination of IMT-009 with Anti-PD1 Immunotherapy at the AACR 2024 Annual Meeting
-
Flare Therapeutics to Present Immune Profiling Data from Urothelial Cancer Patients Treated with Anti-PD1 Therapy at AACR 2024 Annual Meeting
-
Charter to Participate in Deutsche Bank Media, Internet & Telecom Conference
-
Bit Digital, Inc. Announces Monthly Production Update for February 2024
-
Aadi Bioscience to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024
-
Hummingbird Bioscience to Present Two Posters on Anti-HER3 and Anti-VISTA Antibody Therapeutics at American Association for Cancer Research (AACR) Meeting 2024
-
Myeloid Therapeutics to Provide Updates on its RNA Immunotherapies at Multiple Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2024
-
GV20 Therapeutics Announces Oral Presentation on GV20-0251 for Solid Tumors Targeting IGSF8 at AACR Annual Meeting 2024
-
Sapience Therapeutics to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024
-
NASA Opens Astronaut Applications as Newest Class Graduates
-
Ellomay Capital Announces Launch of its First Photovoltaic Projects in Texas
-
GFL Environmental Inc. Announces Closing of Secondary Offering by Selling Shareholders
